Reagents needed by the department of transfusion medicine (DTM) for patient and donor testing.

Ended Awarded

Contract number
75N90022F00026
Awardee
Awarding agency
Obligated
$18,919

Award facts

Contract value 100% obligated
$18,919.38 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
325413 In-Vitro Diagnostic Substance Manufacturing
PSC
6505 Drugs And Biologicals
Set-aside
No set-aside
Competition
Full and Open Competition · 2 offers Multiple Award, Fair Opportunity
Pricing
Firm Fixed Price
Place of performance
Newtown, PA 18940, USA

Award details come from SAM.gov/FPDS.

About this award

This delivery order for $18,919.38 was awarded against the Department of Health and Human Services' National Institutes of Health Clinical Center's master GSA Schedule contract for invitro diagnostics, reagents, and tests. It is for reagents needed by the Department of Transfusion Medicine at the Clinical Center for patient and donor testing, to be delivered by February 2023. The prime contractor is Quotient Biodiagnostics, Inc. located in Newtown, Pennsylvania. No set-aside designation was used for this order.

Quick answers

Who was awarded contract 75N90022F00026?

75N90022F00026 was awarded to Alba Bioscience, Inc. by NIH Clinical Center (National Institutes of Health) on January 11, 2022.

How much is contract 75N90022F00026 worth?

The government has obligated $18,919 on 75N90022F00026.

Is contract 75N90022F00026 an order under another contract?

Yes. 75N90022F00026 is a delivery order under 36F79721D0259, a federal supply schedule, on Invitro Diagnostics, Reagents, Test (FSS-65-VII).

Was contract 75N90022F00026 competed?

The extent of competition for 75N90022F00026 was full and open competition. The government received 2 offers.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award